Media Coverage

See what others have said about us.

A Future Beyond Animal Testing: Why ORIVA Matters and How Computational Models Bridge the Gap

Published in GEN (Genetic Engineering & Biotechnology News)

Read More
A Future Beyond Animal Testing: Why ORIVA Matters and How Computational Models Bridge the GapA Future Beyond Animal Testing: Why ORIVA Matters and How Computational Models Bridge the Gap

AI now develops drugs faster than humans. Is that a good thing?

Published in LAist/AirTalk by NPR

Read More
AI now develops drugs faster than humans. Is that a good thing?AI now develops drugs faster than humans. Is that a good thing?

Can Patients Trust a Drug Designed By AI?

Published in Technology Networks

Read More
Can Patients Trust a Drug Designed By AI?Can Patients Trust a Drug Designed By AI?

How AI Is Transforming Drug Development: Jo Varshney, PhD, DVM

Published in American Journal of Managed Care

Read More
How AI Is Transforming Drug Development: Jo Varshney, PhD, DVMHow AI Is Transforming Drug Development: Jo Varshney, PhD, DVM

How Do We Build Trust and Transparency in AI?

Published in The Medicine Maker

Read More
How Do We Build Trust and Transparency in AI?How Do We Build Trust and Transparency in AI?

AI is reshaping drug discovery - Now it must prove it can be trusted

Published in Pharmaphorum

Read More
AI is reshaping drug discovery - Now it must prove it can be trustedAI is reshaping drug discovery - Now it must prove it can be trusted

From preclinical to clinic faster with mechanistic modeling and AI

Published in Drug Discovery News

Read More
From preclinical to clinic faster with mechanistic modeling and AIFrom preclinical to clinic faster with mechanistic modeling and AI

Hybrid AI Is Reshaping Drug Development—But Will Transparency Be the Ultimate Proof of Safety?

Published in Marksmen Daily

Read More
Hybrid AI Is Reshaping Drug Development—But Will Transparency Be the Ultimate Proof of Safety?Hybrid AI Is Reshaping Drug Development—But Will Transparency Be the Ultimate Proof of Safety?

VeriSIM delivering predictive insights to advance and de-risk drug development

Published in BioTuesdays

Read More
VeriSIM delivering predictive insights to advance and de-risk drug developmentVeriSIM delivering predictive insights to advance and de-risk drug development

How AI Can Act as the Lifeline that Counteracts FDA Staffing and Funding Shortages

Published in Marksmen Daily

Read More
How AI Can Act as the Lifeline that Counteracts FDA Staffing and Funding ShortagesHow AI Can Act as the Lifeline that Counteracts FDA Staffing and Funding Shortages

Maximizing Biotech Investment Returns with AI

Published in Informa TechTarget

Read More
Maximizing Biotech Investment Returns with AIMaximizing Biotech Investment Returns with AI

Research Budget Cuts Are Testing AI's Limits

Published in Newsweek

Read More
Research Budget Cuts Are Testing AI's LimitsResearch Budget Cuts Are Testing AI's Limits

Breaking barriers: Female CEO success in a male-dominated industry

Published in BioXConomy

Read More
Breaking barriers: Female CEO success in a male-dominated industryBreaking barriers: Female CEO success in a male-dominated industry

2025 pharma predictions

Published in Pharmaceutical Manufacturing

Read More
2025 pharma predictions2025 pharma predictions

Is AI truly transforming drug development, or are we still navigating through the hype?

Published in Pharma's Almanac

Read More
Is AI truly transforming drug development, or are we still navigating through the hype?Is AI truly transforming drug development, or are we still navigating through the hype?
Connect With Us